Pneumococcal infection in adults: burden of disease.
Drijkoningen JJ, Rohde GG.
Clin Microbiol Infect. 2014 May;20 Suppl 5:45-51. doi: 10.1111/1469-0691.12461. Epub 2014 Jan 24.
Protecting adults at risk of pneumococcal infection and influenza from exposure to SARS-CoV-2.
McIntosh EDG, Feemster K, Rello J.
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-7. doi: 10.1080/21645515.2021.1957647. Epub 2021 Aug 18.
Pathogenesis of pneumococcal infection.
Tuomanen EI, Austrian R, Masure HR.
N Engl J Med. 1995 May 11;332(19):1280-4. doi: 10.1056/NEJM199505113321907.
Pneumococcal infection and pneumococcal vaccine.
Austrian R.
N Engl J Med. 1977 Oct 27;297(17):938-9. doi: 10.1056/NEJM197710272971712.
Pneumococcal infection.
Austrian R.
Prev Med. 1974 Dec;3(4):443-5. doi: 10.1016/0091-7435(74)90004-8.
The biology of pneumococcal infection.
Tuomanen EI.
Pediatr Res. 1997 Sep;42(3):253-8. doi: 10.1203/00006450-199709000-00001.
Effective prevention of secondary pneumococcal infection following influenza virus infection.
Seon SH, Rhee DK.
Future Microbiol. 2018 Jul;13:953-955. doi: 10.2217/fmb-2018-0129. Epub 2018 Jun 27.
Unusual manifestations of invasive pneumococcal infection.
Taylor SN, Sanders CV.
Am J Med. 1999 Jul 26;107(1A):12S-27S. doi: 10.1016/s0002-9343(99)00103-5.
Pathogenesis of pneumococcal infection.
Gillespie SH, Balakrishnan I.
J Med Microbiol. 2000 Dec;49(12):1057-1067. doi: 10.1099/0022-1317-49-12-1057.
The epidemiology of pneumococcal infection in children in the developing world.
Greenwood B.
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):777-85. doi: 10.1098/rstb.1999.0430.
